Literature DB >> 5630225

Mechanism by which fiber antigen inhibits multiplication of type 5 adenovirus.

A J Levine, H S Ginsberg.   

Abstract

Purified fiber antigen of type 5 adenovirus inhibited the multiplication of type 5 adenovirus by 50% when 35 mug of fiber antigen protein was added to 10(6) KB cells in suspension culture. Although the fiber antigen reduced the number of virions adsorbed per cell when a multiplicity of infection of 50,000 plaque-forming units (PFU)/cell was employed, the number of cells infected was not diminished under these conditions. If a low multiplicity of infection (1.1 PFU/cell) was used, viral adsorption was not detectably decreased. The fiber antigen did not reduce the capability of virions to liberate their viral deoxyribonucleic acid (DNA). The biosyntheses of DNA, ribonucleic acid (RNA), and protein were blocked about 20 to 25 hr after the addition of fiber antigen to cultures of uninfected or type 5 adenovirus-infected KB cells. Most of the fiber antigen protein became cell-associated between 22 and 36 hr after it was added to cells. The hexon antigen neither inhibited viral multiplication nor blocked the biosynthesis of DNA, RNA, or protein. Moreover, the hexon did not attach to KB cells. The profound effects of the fiber antigen were not due to the induction of an interferon-like substance, for actinomycin D did not reduce the ability of the fiber to inhibit multiplication of type 1 poliovirus.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5630225      PMCID: PMC375350     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  ENHANCEMENT OF CHIKUNGUNYA VIRUS REPLICATION AND INHIBITION OF INTERFERON PRODUCTION BY ACTINOMYCIN D.

Authors:  E HELLER
Journal:  Virology       Date:  1963-12       Impact factor: 3.616

2.  PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.

Authors:  W C WILCOX; H S GINSBERG
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

3.  RNA synthesis in poliovirus-infected cells.

Authors:  E F ZIMMERMAN; M HEETER; J E DARNELL
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

4.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

5.  The purification and concentration of viruses and virus soluble antigens on calcium phosphate.

Authors:  J TAVERNE; J H MARSHALL; F FULTON
Journal:  J Gen Microbiol       Date:  1958-12

6.  Propagation in a fluid medium of a human epidermoid carcinoma, strain KB.

Authors:  H EAGLE
Journal:  Proc Soc Exp Biol Med       Date:  1955-07

7.  Qualitative and quantitative colorimetric determination of heptoses.

Authors:  Z DISCHE
Journal:  J Biol Chem       Date:  1953-10       Impact factor: 5.157

8.  Inhibition of DNA polymerase by histones.

Authors:  L R Gurley; J L Irvin; D J Holbrook
Journal:  Biochem Biophys Res Commun       Date:  1964       Impact factor: 3.575

9.  Characterization of a Tumorlike Antigen in Type 12 and Type 18 Adenovirus-Infected Cells.

Authors:  Z Gilead; H S Ginsberg
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

10.  Inhibition of interferon action by actinomycin.

Authors:  J Taylor
Journal:  Biochem Biophys Res Commun       Date:  1964       Impact factor: 3.575

View more
  35 in total

1.  Hexon peptides of type 2, 3, and 5 adenoviruses and their relationship to hexon structure.

Authors:  M F Stinski; H S Ginsberg
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Characterization of type 5 adenovirus fiber protein.

Authors:  P H Dorsett; H S G8nsberg
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

3.  Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.

Authors:  Zeng B Zhu; Angel A Rivera; Sharmila K Makhija; Baogen Lu; Minghui Wang; Miiru Izumi; Robert J Cerfolio; Mariam A Stoff-Khalili; Fen Zhou; Koichi Takayama; Gene P Siegal; David T Curiel
Journal:  Lung Cancer       Date:  2006-11-17       Impact factor: 5.705

4.  Degradation of cellular mRNA during infection by herpes simplex virus.

Authors:  Y Nishioka; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

5.  Alterations in the protein synthetic apparatus of Friend erythroleukemia cells infected with vesicular stomatitis virus or herpes simplex virus.

Authors:  Y Nishioka; S Silverstein
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

6.  Requirement of protein synthesis for the degradation of host mRNA in Friend erythroleukemia cells infected wtih herpes simplex virus type 1.

Authors:  Y Nishioka; S Silverstein
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

7.  Transient inhibition of polyoma virus synthesis by sendai virus (parainfluenza I). II. Mechanism of the interference by inactivated virus.

Authors:  G L Smith; R A Consigli
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

8.  Synthesis, transport, and morphogenesis of type adenovirus capsid proteins.

Authors:  L F Velicer; H S Ginsberg
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

9.  Herpes simplex virus types 1 and 2 induce shutoff of host protein synthesis by different mechanisms in Friend erythroleukemia cells.

Authors:  T M Hill; R R Sinden; J R Sadler
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

10.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.